Transcript Highlights:

• I never needed a benzodiazepine.
• exposure and the non-benzodiazepine drugs.
• non-benzodiazepine hypnotics.
• Thank you for holding this hearing today for House Bill H. 2,223, and act relative to benzodiazepines
• The list of benzodiazepine symptoms is endless, and yes, benzos are great for short-term treatment of

Keywords: 995, all

Summary: The hearing opened with remarks from House Chair Mindy Domb and Senate Vice Chair Robyn Kennedy, who outlined procedures for the hybrid public hearing, noted the committee would hear testimony on 15 bills related to treatment settings, and recognized members present. The first major bill discussed was H. 4200, authorizing a pilot program for psychedelic-assisted treatment in licensed facilities. Representative Jim O’Day and witnesses from Control Z supported the bill, describing it as a tightly controlled, medically supervised pilot with DPH oversight, limited sites, and screening requirements. Committee members asked about the number of sites and whether Column Health still existed; witnesses said the bill contemplated three separate pilot programs and that Column Health no longer existed after being purchased by another company. The committee also heard testimony on S. 1405 to make the drug stewardship program permanent by removing its 2026 sunset date. Senator John Keenan and others said the program helps collect and safely dispose of unused medications, reduces diversion, and should remain in place because manufacturers should bear disposal costs. A member from Boston added support based on local concerns about people searching through bags for drugs, and Keenan explained the original sunset reflected pilot status and industry pushback. A large portion of the hearing focused on S. 1394 and H. 2193, which would strengthen implementation of the 2023 Roadmap for Behavioral Health Reform. The Children’s Mental Health Campaign, Parent/Professional Advocacy League, Massachusetts Association for Mental Health, and Elliott Community Human Services testified that the roadmap’s helpline, community behavioral health centers, and crisis services are important but unevenly implemented. They urged a single point of accountability within EOHHS, regular strategic planning, a public data dashboard, and financial analysis of the behavioral health system and the access and crisis intervention trust fund. Witnesses said commercial insurance often does not fully reimburse community behavioral health center services, making sustainability difficult, and asked for better coordination across agencies and crisis response systems. Committee members asked whether the roadmap includes substance use disorder; witnesses said it is intended to cover behavioral health broadly, including mental health and substance use. The committee also heard testimony on bills to ban aversives and on suicide prevention signage. Lisa Jean Graff testified in support of S. 1394 by urging a statewide ban on aversive practices, including electric shock, withholding food or bathroom access, and other painful interventions, arguing disabled people deserve the same protections from harm as others. Fonda Bryant and Carol McLean supported a bill requiring suicide prevention signs on tall parking garages, describing personal experiences and saying the signs could create a brief pause and connect people to 988 or other help. McLean said her son died by suicide from a parking garage and that signage might have made a difference. The committee also heard strong testimony in support of creating intensive stabilization and treatment units within DMH facilities (S. 1398/H. 2204), with the Massachusetts Nurses Association and a DMH nurse arguing that highly assaultive patients need specialized, more secure units to protect staff and other patients and to improve care. Additional testimony supported creating a dedicated board for licensed mental health counselors (H. 4696/S. 1382), with Rep. John Badger, the Mass Mental Health Counselors Association, and others saying LMHCs are a large and growing workforce that needs its own licensing board, clearer standards, and faster implementation of existing licensure reforms. The committee also heard extensive testimony on H. 2223 regarding benzodiazepines and non-benzodiazepine hypnotics. Survivors and advocates described severe withdrawal, lack of informed consent, cognitive harms, and long-term disability, while a physician supported the bill as a way to improve disclosure of risks. Finally, the committee heard multiple witnesses in favor of H. 2231/S. 1383 to establish peer-run respite centers statewide. Advocates and people with lived experience said peer respites provide non-coercive, home-like alternatives to hospitalization, can reduce trauma and repeated admissions, and may be especially important for marginalized communities; they also cited cost savings and existing positive outcomes from current respite programs. No votes or final committee actions were taken during the hearing portion reflected in the transcript.

Transcript Highlights:

• Physiological dependence is a property of many medicines, including benzodiazepines and antidepressants
• Yes, it's costly, and we've seen outside in the community here the co-prescribing of benzodiazepines,
• diverted because what they do with the drug is people divert this so that they can use it with benzodiazepines
• diverted because what they do with the drug is people divert this so that they can use it with benzodiazepines
• diverted because what they do with the drug is people divert this so that they can use it with benzodiazepines

Keywords: 958, all

Summary: The subcommittee met on October 14, approved the minutes, and then took up a large group of staff-suggested amendments to multiple regulations. Those staff amendments were approved without objection and were described as technical changes needed to comply with KRS Chapter 13A and other governing law. The committee then moved out of order to consider Kentucky Board of Medical Licensure regulation 2011 KAR 9:270, which governs buprenorphine prescribing and related standards. Board representatives said the regulation has been updated over time since 2015 and that the current amendments are intended to streamline the rule, remove outdated federal references such as the X-waiver, narrow education requirements to addiction-related topics, and create exceptions for settings like emergency rooms and certain pain treatment situations. The agency amendment would also allow buprenorphine monoproduct for up to 30 days when a patient is transitioning from a full opioid agonist, and would add physicians certified in addiction medicine as eligible specialty consultants. Board officials said the regulation was developed through a two-year process with a work group, informal outreach to medical organizations, and multiple comment periods, and they argued the rule is working because overdose deaths have declined and provider numbers have increased. Several witnesses and committee members raised concerns that the regulation remains too restrictive. Senator Rocky Adams noted that major medical organizations had said the proposed language could restrict access and worsen overdose risk, and he questioned whether the committee was being asked to choose between conflicting expert views. Opponents, including a medical student, a recovery advocate, and Dr. Colleen Ryan of the Kentucky Society of Addiction Medicine, argued the rule is outdated, creates unnecessary barriers to buprenorphine treatment, and should be repealed or substantially revised to align with federal guidance and evidence-based care. They said rigid requirements can discourage treatment and that addiction should be treated like other chronic illnesses. No final vote on the medical licensure regulation is reflected in the transcript excerpt, and the discussion ended with the chair preparing to hear from additional opponents.

Transcript Highlights:

• An act to amend the Mental Hygiene Law in relation to establishing a medetomidine, benzodiazepine, xylazine

Keywords: 993, senate, all

Summary: The committee met for its final meeting of the year and opened with brief remarks thanking members for their participation and noting continued work on addiction services and substance use disorder issues, including efforts to reduce stigma and support funding in the budget. The agenda consisted of three bills related to harm reduction and drug checking. The committee first considered S. 246, which would establish a wound care kit and testing strip distribution program; it was moved, approved unanimously, and reported to Finance. Next, S. 4640A would authorize on-site overdose response services and require certain venues to maintain opioid antagonists; it was also approved unanimously and reported to the calendar. The third bill, S. 9221, would create a program to test for medetomidine, benzodiazepines, xylazine, and other harmful contaminants; members discussed the changing drug supply and the need for drug checking, then approved the bill unanimously. At the close, the chair thanked members for their work and adjourned the meeting, noting it was the last committee meeting of the year.

Transcript Highlights:

• Another medication that he has to take is a benzodiazepine.
• It’s a benzodiazepine. It’s called midazolam. And he takes it intranasally.
• So it's no opioids, opioid derivatives, no benzodiazepines, and then from there, MD oversight for any

Summary: The committee first heard and favorably reported SB 255, which expands eligibility for psychosocial rehabilitation services by adding health sciences and therapeutic recreation degrees to the list of acceptable educational backgrounds. Supporters said the change would help address workforce shortages and improve access in rural areas. SB 314 was then reported favorably; it cleans up prior law so a limited scope certified social worker license can still be used for community psychiatric support and treatment services even if the application is filed after the CSW license has expired, rather than being barred by a timing restriction. The committee next took up several bills by Chairman McMath. SB 26, which repeals facility need review requirements for opioid treatment programs, was reported favorably after members and witnesses said Louisiana has too few OTPs and that removing the review would improve access, especially in rural areas. SB 29, requiring review and reporting of a child’s immunization records in certain unexpected death autopsies, was reported favorably despite questions about whether the bill should refer more broadly to medical records; supporters said the data could help evaluate vaccine-related concerns, while opponents raised concerns about singling out immunizations. SB 30, dealing with telehealth for obesity/weight management, was amended and reported favorably; the committee adopted technical amendments and a conceptual amendment replacing “metabolic condition” with “weight management services,” while witnesses debated patient safety, board authority, and whether the bill should limit agencies’ ability to restrict telehealth in the future. The committee also reported favorably SB 219, which creates an Office of Health and Nutrition within LDH. Supporters from the department, the Alzheimer’s Association, and Pennington Biomedical said the office would strengthen coordination on nutrition, physical activity, and brain health, and cited high Alzheimer’s costs and prevalence in Louisiana. SB 222, which streamlines Medicaid behavioral health administrative requirements and expands telehealth for psychosocial rehabilitation, was reported favorably with amendments after supporters described workforce and rural access barriers. SB 195, the “Danny’s Dose EMS Treatment Act,” was reported favorably; it would allow EMS personnel to administer a patient’s own prescribed time-critical medication in emergencies, and testimony from a parent and physician described life-threatening delays under current practice. The committee also adopted SCR 2, updating hospital architectural standards to the most recent Facility Guidelines Institute edition, and SCR 22, requesting a more detailed legislative auditor report on opioid settlement expenditures; members said they wanted clearer outcome data and planned to refine the language before floor debate. Finally, HB 1093 on naturopathic medicine was introduced and heavily amended, with the bill shifted under LSBME oversight and a large set of changes discussed, but no final action was taken in the portion provided.

Transcript Highlights:

• For sedatives or benzodiazepines, we typically use those to help most patients.

Transcript Highlights:

• She didn't tolerate the typical narcotics or sedatives or benzodiazepines we use to help most patients

Transcript Highlights:

• while I was working up at the Center for Human Toxicology as a research toxicologist studying benzodiazepines
• Studying benzodiazepines and opiates and their drug-drug interactions.

Keywords: 985, all

Transcript Highlights:

• just briefly go through the importance of them and how they differ between opioid stimulants and benzodiazepines
• differ between opioid<01:18:55.640> stimulants<01:18:56.280> and<01:18:56.440> benzodiazepines
• opioid stimulants and benzodiazepines. opioid stimulants and benzodiazepines.

Keywords: 1189, house, all

Summary: The committee met on May 29 and approved the draft minutes. DHHS Commissioner Weaver then opened the department update by asking Medicaid Director Henry Litman to brief members on federal and state Medicaid changes, and later turned to DHHS Chief Operating Officer David Weathers for an update on data governance. Members also asked that acronyms be spelled out in future materials and requested a follow-up on the federal Medicaid rule once it is published. Litman reviewed several federal Medicaid provisions tied to HR 1/"OBBA" and related state implementation issues. He said the first major change would be restrictions on certain non-citizens’ Medicaid coverage, affecting about 400 people in New Hampshire, with notices likely 30 to 60 days before the effective date. He also discussed new work requirements/community engagement rules, saying New Hampshire is on track to implement them and will likely need a state plan amendment rather than an 1115 waiver. Other changes included shorter retroactive coverage periods, a new state option for certain community-based services with an estimated $740,000 in implementation support, a freeze and phased-down reduction in the Medicaid enhancement tax beginning in state fiscal year 2029, and limits on directed payments to hospitals after a grandfathering period. He also noted that Medicaid enrollment has fallen from pandemic-era levels, with about 167,000 people covered as of May 1, and that the department is working with CMS on child premiums and other cost-sharing changes approved in HB 2. Committee members asked how the department could plan for the 2029 changes given the number of elections before then, and Litman said federal rules may be adjusted over time as states and stakeholders raise concerns. He emphasized planning for the worst while hoping for the best, and said rural health care transformation funding would help the state prepare. In the second presentation, Weathers explained that data governance is now embedded in DHHS operations to control access, manage reporting, and respond to risk. He defined it as managing what data is collected, how it is used, who can access it, and what laws apply, and said DHHS has moved from governance as a committee to governance as an operational process. He described privacy impact assessments for new systems going into production, monthly privacy and security training, and ongoing review of access controls and data-sharing rules.

Transcript Highlights:

• reductions in use of the top three substances that people overdose on every single day: opiates, benzodiazepines
• reductions in use of the top three substances that people overdose on every single day: opiates, benzodiazepines
• reductions in use of the top three substances that people overdose on every single day: opiates, benzodiazepines
• reductions in use of the top three substances that people overdose on every single day: opiates, benzodiazepines
• reductions in use of the top three substances that people overdose on every single day: opiates, benzodiazepines

Keywords: 910, house, all

Summary: The House Committees on Judiciary and Hawaiian Affairs and Agriculture and Food Systems heard testimony and began decision-making on HB 1246, which would establish the Hawaii Cannabis and Hemp Office within DCCA to regulate cannabis. Chair Tarnas described the bill as divisive and noted the hearing had received 95 testimonies in support, 135 in opposition, and 11 comments. Members were told the office would be administratively attached to DCCA, and the department emphasized it would not direct day-to-day operations. DCCA also raised concerns about banking access due to federal law, while the Department of Agriculture supported a one-plant, one-agency approach and noted its current authority over cannabis plant importation and movement. Several agencies and advocates supported the bill with cautions or requested amendments. The Department of Health said it appreciated the bill’s public health protections but remained concerned about increased adult-use access, youth mental health, pregnancy-related risks, and effects on developing brains; it requested a 12-month delayed effective date. The Attorney General’s office said legalization should include safeguards, recommended a longer implementation timeline and seed funding, and flagged issues in the bill involving impaired driving, open-container language, and penalties for under-21 possession. The Office of the Public Defender supported the bill but objected to new driving and possession offenses, saying existing law already covers impaired driving. Doctors for Drug Policy Reform supported the measure, citing regulation of intoxicating cannabinoids, testing, childproof packaging, and public education as public-health benefits. Opponents focused on youth access, public safety, and the bill’s broader social effects. The Honolulu Police Department opposed the bill over access and diversion concerns, and the City and County of Honolulu Prosecutor strongly opposed legalization, citing higher-potency cannabis, youth harms, psychiatric risks, and increased poison-center calls. The Hawaiʻi Substance Abuse Coalition argued legalization should wait until prevention programs are in place and funded first, while the Hawaiʻi Family Forum and Hawaiian Republican Women also opposed the measure, citing concerns about youth exposure, added bureaucracy, and taxpayer costs. The Tax Foundation of Hawaiʻi questioned the purpose of the proposed cannabis taxes, asking why cannabis should be taxed heavily if legalization is intended. The hearing continued with additional testimony after a brief audio issue for one testifier.

Transcript Highlights:

• are more likely to prescribe anti psychotic STA children, and they're more likely to prescribe benzodiazepines

Transcript Highlights:

• I think that we have to have a latitude also if we're looking at narcotics, benzodiazepines, different

Bills: HB3239, HB3391, HB3557, HB4128

Keywords: veterinary medicine, definitions, animal husbandry, board of veterinary examiners, telemedicine, veterinarian-client relationship, animal welfare, commercial pet breeders, licensing, advertising, animal cruelty, Oklahoma Agricultural Extension, local funding, financial institutions, county extension services, state funds, wildlife conservation, hunting regulations, mountain lions, black bears

Transcript Highlights:

• Another medication that he has to take is a benzodiazepine.
• So it's no opioids, opioid derivatives, no benzodiazepines, and then from there, MD oversight for any

Bills: HB946, HB1093, SB26, SB29, SB30, SB195, SB219, SB222, SB255, SB314, SCR2, SCR22

Keywords: healthcare transparency, hospital pricing, consumer protection, collection actions, fines, naturopathic medicine, Louisiana Board of Naturopathic Medicine, licensing, healthcare, prescriptive authority, natural therapies, opioid treatment, regulation, addiction recovery, state law, SB 29, Act 732, coroner, autopsy, child death

Transcript Highlights:

• I think that we have to have a latitude also, if we're looking at narcotics, benzodiazepines, different

Bills: HB3239, HB3391, HB3557, HB4128

Keywords: veterinary medicine, definitions, animal husbandry, board of veterinary examiners, telemedicine, veterinarian-client relationship, animal welfare, commercial pet breeders, licensing, advertising, animal cruelty, Oklahoma Agricultural Extension, local funding, financial institutions, county extension services, state funds, wildlife conservation, hunting regulations, mountain lions, black bears

Summary: The Agriculture Committee first considered two executive nominations and approved both unanimously. Rebecca Hartfield was re-nominated to the State Board of Veterinary Medical Examiners, where she described her rural mixed-animal veterinary work and efforts to encourage future veterinarians. James Harrell was then nominated to the Oklahoma State University Veterinary Medical Authority; supporters emphasized his commitment to rural Oklahoma and addressing the shortage of large-animal veterinarians, and he discussed efforts to improve veterinary education and recruit more Oklahoma students. Both nominations passed 13-0. The committee then took up House Bill 3391, which would add improper advertising as a basis for revoking a commercial pet breeder license and define advertising to include digital and social media. Members asked about the definition and scope of commercial pet breeders. The bill passed on a 9-4 vote. House Bill 4128, dealing with black bear hunting season and harvest limits, drew extensive debate. An amendment to move the opener to September 21, expand counties, and let the Wildlife Commission set quotas failed 6-7. The underlying bill, which would have kept the September 15 opener and a 200-bear limit, also failed 3-9 after testimony and debate focused on bear population data, nuisance complaints, and concerns about out-of-state hunters and impacts on female bears. House Bill 3557, which would keep locally raised county extension funds in separate accounts so they are not swept into state accounts, passed 10-2 after questions about how local, state, and federal funds would be handled. Finally, House Bill 3239 on veterinary telemedicine passed 9-3. The bill defines the veterinarian-client relationship needed before telemedicine can be used, with supporters saying it would provide needed structure while preserving access for rural livestock care; opponents worried it could restrict access in emergencies. The committee then adjourned.

Transcript Highlights:

• had alcohol use disorder, they would admit them to the hospital, give them a lowering dosage of benzodiazepines
• me to repeat it, I would do it, because we'd be called many times at night to say, what is the benzodiazepine

Summary: The meeting focused on Missouri’s substance use prevention and treatment system, with repeated emphasis on recovery support services, peer support, recovery housing, transportation, and harm reduction. Dan Haniken of Into Action described his own recovery from addiction and incarceration and argued that treatment alone is not enough; he urged greater investment in recovery housing, peer support, employment, and community-based supports that help people stay sober and avoid relapse. Members asked about funding sources, program capacity, referrals, treatment court, transportation, and how Into Action supports people on medication-assisted treatment (MAT). Haniken said the organization is funded through a mix of federal, state, county, city, foundation, and private donations, and that housing and transportation remain major barriers, especially because support is often funded for too short a period compared with the longer time people need to stabilize. Matt Cushman of the Raytown Fire Protection District gave a strong endorsement of harm reduction, including naloxone distribution, syringe service programs, and broader decriminalization of harm reduction tools. He argued that stigma is a major barrier to care and that Missouri should expand access to clean needles, test strips, and other services, while also improving access to MAT in jails and communities. Committee members questioned the evidence base, the role of faith-based providers, and whether safe consumption sites should be pursued; Cushman said syringe exchange decriminalization should be the immediate priority, while safe consumption sites are a longer-term issue. He also described community paramedicine and mobile integrated health as valuable but funding-dependent, and said naloxone distribution is improving but still uneven, especially in rural and minority communities. Representatives from Central Ozarks Medical Center and Four Rivers Community Health Center highlighted the importance of peer support specialists, community health workers, care coordinators, and wraparound services in rural health centers. COMC’s Morgan McClure and Monet Lehman described a jail reentry program in Pulaski County, with Lehman sharing her trauma and recovery story and explaining how she helps incarcerated people prepare for release with housing, employment, benefits, transportation, and treatment connections. Four Rivers’ Devon Polarys and Cassandra Trout said their CEO would change Missouri policy to allow FQHCs to receive reimbursement for peer support and community health worker services similar to CCBHCs, arguing that these roles are essential for addressing barriers like transportation, housing, food insecurity, and insurance. Members discussed confusion over reimbursement rules, the differences between FQHCs and CCBHCs, and the need for better funding and clearer policy for peer and community health worker services. No votes were taken; the discussion ended with a suggestion to bring in a subject matter expert on community health workers for a future session.

Transcript Highlights:

• curriculum, is that the two drug classes that have deadly withdrawals and detoxes are alcohol and benzodiazepines
• curriculum, is that the two drug classes that have deadly withdrawals and detoxes are alcohol and benzodiazepines

Keywords: 959, house, all

Transcript Highlights:

• Much the level of intoxication from alcohol, but the people are mixing that with benzodiazepines and

Keywords: 1184, house, all

Transcript Highlights:

• had alcohol use disorder, they would admit them to the hospital, give them a lowering dosage of benzodiazepines
• me to repeat it, I would do it, because we'd be called many times at night to say, what is the benzodiazepine

Keywords: 959, house, all

Transcript Highlights:

• They and their families are desperately seeking alternatives to addictive opiates, benzodiazepines, and

Keywords: 988, house, all

Transcript Highlights:

• The toxicology report came back, and she was high on opioids and benzodiazepines. 2 kinds of oxy and

Bills: HB153

Transcript Highlights:

• The toxicology report came back: she was high on opioids and benzodiazepines.

Bills: HB153, HB1410, HB1461, HB1760, HB1762, HB3261, HB3773, HB153

Keywords: education, funding, student resources, technology access, equal opportunity, veterans treatment court, mental health, criminal justice, rehabilitation, eligibility criteria, veterans, treatment court, military service, legislation, private prisons, inmate confinement, criminal justice reform, Texas Department of Criminal Justice, government contracts, inmate housing